Bioreactors Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2026: Graphical Research

Major bioreactors market players include Sartorius Stedim Biotech, Merck, Thermo Fisher Scientific, and Eppendorf AG, Pierre Guerin Sas, and Danaher Corporation (Cytiva).

Pune, India, March 11, 2021 (GLOBE NEWSWIRE) --

The global bioreactors market is predicted to witness substantial growth rate during the forecast period. With the augmented demand for the development of protein therapeutics, monoclonal antibodies, and cytokines in the light of the present and future pandemics, the deployment of bioreactors across the pharmaceutical industry is certain to witness an uptick. The emergence of new trends such as the use of offsite bioreactors that offer immediate access to experiment results has been spurring the demand for these systems on an international scale as the volume of drug development initiatives has been expanding.

The top six trends that have been inciting the growth of the global bioreactors industry forecast are as follows:

Bacterial cells segment to soar in Europe

The Europe bioreactors market forecast is likely to benefit to a great degree as the usage of bacterial cells in pharmaceutical applications has been escalating in the recent times. The segment was estimated at $265 million during 2019. The growing need for these cells originating from manufacturers of pharmaceuticals and enzymes is responsible for this trend.

Bacterial cells are less vulnerable to shear damage and provide higher productivity as compared to other cells. The better oxygen and nutrient supply ensured by the usage of these cells has been encouraging their adoption in bioreactor systems.

Access sample pages of the report, “Europe Bioreactors Market Forecasts 2026” in detail along with the table of contents (ToC) @

Growth in healthcare funding across the U.K.

The U.K. bioreactors market size is expected to grow at a high CAGR of more than 13.8% through 2026, assisted by the thriving biotechnology sector in the region. The growth in healthcare expenditure from both private as well as public organizations has been pushing the demand for bioreactors in the region.

The presence of numerous industry players as well as funding agencies including the Biotechnology and Biological Sciences Research Council (BBSRC) has been promoting expansion of the industry. These bodies have been harnessing bioreactors for research and training purposes. Such initiatives by the national agencies is likely to induce higher demand for bioreactors across the nation.

Single-use bioreactors to see higher deployment in Europe

In terms of type, the Europe bioreactors industry share has been bifurcated into reusable bioreactors and single-use bioreactors. The single-use segment is slated to possess a considerable industry share by 2026, growing at a 16.7% CAGR over the coming years.

Biomanufacturing facilities have been embracing these systems as they provide more convenience when multiple low-volume products are to be manufactured along the same floor of the manufacturing unit. As they can save on space and boost flexibility, at the same time reducing the risk of cross-contamination, single-use bioreactors are gaining momentum especially in the wake of the pandemic. 

Growing demand for vaccines in North America

The vaccines segment of the North America bioreactors market has been registering high demand in the recent times, thanks to the rising requirement of vaccines against COVID-19. The industry was valued at $670 million during 2019. The growing prevalence of numerous other infectious and chronic diseases has also been spurring the demand for monoclonal antibodies and cytokines, pushing the expansion of the industry.

As per the estimates of the Centers for Disease Control and Prevention (CDC), more than 15 million individuals with infectious and parasitic diseases visit their physicians in the U.S. Similarly, the findings also reveal that more than 4 million patients who visit the emergency departments of hospitals are later found to be suffering from infectious diseases. The need to address the issue of rapid contagion has been a key driver of the market.

Access sample pages of the report, “North America Bioreactors Market Forecasts 2026” in detail along with the table of contents (ToC) @

Higher usage of mammalian cells in North America

The mammalian cells segment in the North America bioreactors market is poised for remarkable growth and was estimated to be worth $1.2 billion during 2019. The growth in demand can be accredited to the prosperous biopharmaceuticals and biologics industries in the region.

These cells are extensively utilized across clinical laboratories and research centers for the development and manufacturing of advanced biologics. With the growing awareness pertaining to the availability of personalized medicine and orphan drugs, the adoption of mammalian cells is likely to soar.

India to be a major bioreactors consumer

The Asia Pacific bioreactors market share is anticipated to grow steadily over the next few years, as India houses numerous pharmaceutical companies and manufacturing establishments. In India, research institutes, contract research organizations, and pharma companies have been collaborating to translate their research findings into effective pharmaceutical products.

Access sample pages of the report, “Asia Pacific Bioreactors Market Forecasts 2026” in detail along with the table of contents (ToC) @

The country is home to the Serum Institute, which has been mass producing COVID-19 vaccines. These vaccines need to be accurately manufactured to ensure safety and efficiency. As bioreactors are an indispensable tool for growing live cultures, several market players have been investing heftily toward their manufacturing. The region accounted for a share of more than 17% of the total Asia Pacific bioreactors industry share during 2019 and is likely to amass a higher market share by 2026.

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.


Contact Data